IP Library Granted Patent US 7,592,174
Granted Patent B2
US 7,592,174 · App. 11/704,611 · Granted Sep 22, 2009

Isolation of mesenchymal stem cells

Assignee: The Board of Trustees of the Leland Stanford Junior University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,592,174
App. No.
11/704,611
Granted
Sep 22, 2009
Kind
B2
Abstract

Methods and compositions are provided for the identification and isolation of mammalian mesenchymal stem cells. The methods of the invention provide a means to obtain substantially homogeneous MSC populations. In some embodiments, the homogeneous MSC composition is stable in non-differentiating culture conditions, where the proportion of cells in the composition that have an MSC phenotype are maintained over multiple passages.

Claims (14)

1. A method for the isolation of mammalian mesenchymal stem cells (MSC) from bone marrow, the method comprising:

introducing into an in vitro population of mammalian cells isolated from bone marrow a nucleic acid construct comprising sequences encoding a detectable marker, which marker is operably linked to a transcriptional response element regulated by β-catenin, wherein said transcriptional response element is a LEF-1/TCF binding sequence;

detecting the presence of expression of said detectable marker;

selecting for cells expressing said detectable marker; and

wherein expression of said marker is indicative that a cell is an MSC.

2. The method according to claim 1 , wherein said marker is a fluorescence producing protein.

3. The method according to claim 1 , further comprising the step of culturing cells expressing said detectable marker in vitro.

4. The method according to claim 3 ,, wherein said in vitro culture provides non-differentiating conditions.

5. The method according to claim 3 , wherein said in vitro culture provides differentiating conditions.

6. The method according to claim 5 , wherein said culture conditions induce differentiation of at least one of chondrocytes, adipocytes, osteocytes and myocytes.

7. The method according to claim 4 , further comprising the steps of:

culturing said cells for at least one passage; and

selecting for cells expressing said detectable marker.

8. The method according to claim 7 , wherein the selected cells remain non-differentiated for at least five passages in culture.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 28, 2010
From: STANFORD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024754/0739 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Nov 23, 2008
From: STANFORD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021878/0988 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2007
From: SYLVESTER, KARL G.; TATARIA, MONIKA; AILLES, LAURIE; WEISSMAN, IRVING L.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 019707/0552 →
Continuity (5)
Continuation In Part 1044979500 · May 30, 2003
Provisional Application 6077197300 · Feb 10, 2006
Provisional Application 6038452900 · May 31, 2002
Provisional Application 6043165500 · Dec 6, 2002
Related Publication 20070292872A1 · Dec 20, 2007